FASN and nonpapillary renal cell carcinoma: In a study of 126 patients with early‐ to mid‐stage ccRCC, obese patients presented lower expression levels of fatty acid synthase (FASN) but higher expression levels of pathways related to fatty acid metabolism and oxidation [169].